Clinical Trial Update: Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Chronocort with standard glucocorticoid therapy in congenital adrenal hyperplasia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Adrenal Hyperplasia

Drugs mentioned

• Chronocort

Snippet

Sponsor: Neurocrine UK Limited | Conditions: Congenital Adrenal Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-04